Repository logo
 

Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Watson, BNJ 
Easingwood, RA 
Tong, B 
Wolf, M 
Salmond, GPC 

Abstract

CRISPR-Cas systems provide bacteria and archaea with adaptive immunity against genetic invaders, such as bacteriophages. The systems integrate short sequences from the phage genome into the bacterial CRISPR array. These 'spacers' provide sequence-specific immunity but drive natural selection of evolved phage mutants that escape the CRISPR-Cas defence. Spacer acquisition occurs by either naive or primed adaptation. Naive adaptation typically results in the incorporation of a single spacer. By contrast, priming is a positive feedback loop that often results in acquisition of multiple spacers, which occurs when a pre-existing spacer matches the invading phage. We predicted that single and multiple spacers, representative of naive and primed adaptation, respectively, would cause differing outcomes after phage infection. We investigated the response of two phages, ϕTE and ϕM1, to the Pectobacterium atrosepticum type I-F CRISPR-Cas system and observed that escape from single spacers typically occurred via point mutations. Alternatively, phages escaped multiple spacers through deletions, which can occur in genes encoding structural proteins. Cryo-EM analysis of the ϕTE structure revealed shortened tails in escape mutants with tape measure protein deletions. We conclude that CRISPR-Cas systems can drive phage genetic diversity, altering morphology and fitness, through selective pressures arising from naive and primed acquisition events. This article is part of a discussion meeting issue 'The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems'.

Description

Keywords

CRISPR-Cas, bacteriophages, phage evolution, phage morphology, tape measure protein, Bacteriophages, CRISPR-Cas Systems, Pectobacterium, Point Mutation

Journal Title

Philos Trans R Soc Lond B Biol Sci

Conference Name

Journal ISSN

0962-8436
1471-2970

Volume Title

374

Publisher

The Royal Society
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/H002677/1)
Biotechnology and Biological Sciences Research Council (BB/G000298/1)
This work was supported by a Rutherford Discovery Fellow- ship from the Royal Society of New Zealand (RSNZ) (to P.C.F.), the Marsden Fund, RSNZ, the Bio-protection Research Centre (Tertiary Education Commission), a University of Otago Doctoral Scholarship (to B.N.J.W.), University of Otago Division of Health Sciences Career Development Post-doctoral Fellowship and a Veni grant (grant no. 016.Veni.171.047) from the The Netherlands Organization for Scienti- fic Research (to R.H.J.S.). G.P.C.S. was supported by the BBSRC, UK.